{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:30:06Z","timestamp":1792726206295,"version":"4.5.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1001\/jamaoncol.2020.2535","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T15:32:22Z","timestamp":1595518342000},"page":"1355","source":"Crossref","is-referenced-by-count":208,"title":["Association of Event-Free and Distant Recurrence\u2013Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer"],"prefix":"10.1001","volume":"6","author":[{"name":"I-SPY2 Trial Consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Yee","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"DeMichele","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Yau","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Isaacs","sequence":"additional","affiliation":[{"name":"Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Fraser","family":"Symmans","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy S.","family":"Albain","sequence":"additional","affiliation":[{"name":"Loyola University Chicago Stritch School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunn-Yi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Krings","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Datnow","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwole","family":"Fadare","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Pambuccian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiyun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathi","family":"Adamson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Swedish Cancer Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Sams","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"Mhawech-Fauceglia","sequence":"additional","affiliation":[{"name":"Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Magliocco","sequence":"additional","affiliation":[{"name":"Department of Pathology, Moffitt Cancer Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Rendi","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husain","family":"Sattar","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Zeck","sequence":"additional","affiliation":[{"name":"Department of Pathology, Georgetown University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris T.","family":"Ocal","sequence":"additional","affiliation":[{"name":"Laboratory Medicine and Pathology, Mayo Clinic Scottsdale, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama","family":"Tawfik","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Kansas, Lawrence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren Grasso","family":"LeBeau","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Arizona, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunati","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Southwestern, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuyethoa","family":"Vinh","sequence":"additional","affiliation":[{"name":"Inova Pathology Institute, Inova Health System, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Jo","family":"Chien","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Forero-Torres","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of Alabama Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Stringer-Reasor","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of Alabama Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Pusztai","sequence":"additional","affiliation":[{"name":"Medical Oncology, Yale Cancer Center, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic Rochester, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Ellis","sequence":"additional","affiliation":[{"name":"Medical Oncology, Swedish Cancer Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Elias","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Colorado, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Lu","sequence":"additional","affiliation":[{"name":"Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Lang","sequence":"additional","affiliation":[{"name":"Surgery, Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo S.","family":"Han","sequence":"additional","affiliation":[{"name":"Medical Oncology, Moffitt Cancer Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Clark","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Nanda","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, University of Chicago Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald W.","family":"Northfelt","sequence":"additional","affiliation":[{"name":"Medical Oncology, Mayo Clinic Scottsdale, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qamar J.","family":"Khan","sequence":"additional","affiliation":[{"name":"Medical Oncology, University of Kansas Medical Center, Lawrence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Viscusi","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, University of Arizona, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Euhus","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten K.","family":"Edmiston","sequence":"additional","affiliation":[{"name":"Inova Schar Cancer Institute, Fairfax, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Y.","family":"Chui","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Kemmer","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minetta C.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Mayo Clinic Rochester, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunmilayo","family":"Olopade","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, University of Chicago Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Leyland-Jones","sequence":"additional","affiliation":[{"name":"Avera Cancer Institute, Sioux Falls, South Dakota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasish","family":"Tripathy","sequence":"additional","affiliation":[{"name":"Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy L.","family":"Moulder","sequence":"additional","affiliation":[{"name":"Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Schwab","sequence":"additional","affiliation":[{"name":"Medical Oncology, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Lo","sequence":"additional","affiliation":[{"name":"Medical Oncology, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Helsten","sequence":"additional","affiliation":[{"name":"Medical Oncology, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Beckwith","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Haugen","sequence":"additional","affiliation":[{"name":"National Breast Cancer Coalition, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nola M.","family":"Hylton","sequence":"additional","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"van\u2019t Veer","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Perlmutter","sequence":"additional","affiliation":[{"name":"Gemini Group, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Melisko","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wilson","sequence":"additional","affiliation":[{"name":"Quantum Leap Healthcare Collaborative, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Asare","sequence":"additional","affiliation":[{"name":"Quantum Leap Healthcare Collaborative, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith B.","family":"Buxton","sequence":"additional","affiliation":[{"name":"Berry Consultants, LLC, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Paoloni","sequence":"additional","affiliation":[{"name":"Berry Consultants, LLC, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L.","family":"Clennell","sequence":"additional","affiliation":[{"name":"Berry Consultants, LLC, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian L.","family":"Hirst","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Singhrao","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Steeg","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Matthews","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita M.","family":"Asare","sequence":"additional","affiliation":[{"name":"Quantum Leap Healthcare Collaborative, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Sanil","sequence":"additional","affiliation":[{"name":"Berry Consultants, LLC, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Berry","sequence":"additional","affiliation":[{"name":"Berry Consultants, LLC, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Esserman","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald A.","family":"Berry","sequence":"additional","affiliation":[{"name":"Berry Consultants, LLC, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"coi200035r1","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"issue":"13","key":"coi200035r2","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1200\/JCO.2005.04.1665","article-title":"Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27.","volume":"24","author":"Bear","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9938","key":"coi200035r3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"coi200035r6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/clpt.2009.68","article-title":"I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy.","volume":"86","author":"Barker","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"coi200035r7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1513750","article-title":"Adaptive randomization of neratinib in early breast cancer.","volume":"375","author":"Park","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"coi200035r8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1513749","article-title":"Adaptive randomization of veliparib-carboplatin treatment in breast cancer.","volume":"375","author":"Rugo","year":"2016","journal-title":"N Engl J Med"},{"issue":"25","key":"coi200035r9","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer.","volume":"347","author":"van de Vijver","year":"2002","journal-title":"N Engl J Med"},{"issue":"8","key":"coi200035r10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer.","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"issue":"28","key":"coi200035r11","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.","volume":"25","author":"Symmans","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"coi200035r12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group.","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"14","key":"coi200035r13","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1158\/1078-0432.CCR-13-3131","article-title":"Accelerated approval for pertuzumab in the neoadjuvant setting: winds of change?","volume":"20","author":"Esserman","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"4","key":"coi200035r14","article-title":"Abstract P1-14-03: the evaluation of trebananib plus standard neoadjuvant therapy in high-risk breast cancer: results from the I-SPY 2 TRIAL.","volume":"76","author":"Albain","year":"2016","journal-title":"Cancer Res"},{"issue":"4","key":"coi200035r15","article-title":"The evaluation of ganitumab\/metformin plus standard neoadjuvant therapy in high-risk breast cancer: Results from the I-SPY 2 trial (Abstract P6-11-04).","volume":"77","author":"Yee","year":"2017","journal-title":"Cancer Res"},{"issue":"10","key":"coi200035r16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1200\/JCO.19.01027","article-title":"MK-2206 and standard neoadjuvant chemotherapy improves response in patients with human epidermal growth factor receptor 2\u2013positive and\/or hormone receptor\u2013negative breast cancers in the I-SPY 2 trial.","volume":"38","author":"Chien","year":"2020","journal-title":"J Clin Oncol"},{"issue":"14","key":"coi200035r17","article-title":"Efficacy of pertuzumab\/trastuzumab\/paclitaxel over standard trastuzumab\/paclitaxel therapy for HER2+ breast cancer: results from the neoadjuvant I-SPY 2 TRIAL (Abstract CT106).","volume":"76","author":"Buxton","year":"2016","journal-title":"Cancer Res"},{"issue":"14","key":"coi200035r18","article-title":"Efficacy of T-DM1+pertuzumab over standard therapy for HER2+ breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL (Abstract CT042).","volume":"76","author":"DeMichele","year":"2016","journal-title":"Cancer Res"},{"issue":"4","key":"coi200035r19","article-title":"Efficacy of Hsp90 inhibitor ganetespib plus standard neoadjuvant therapy in high-risk breast cancer: results from the I-SPY 2 trial (Abstract P6-11-02).","volume":"77","author":"Forero","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"coi200035r20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41523-019-0112-z","article-title":"A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.","volume":"5","author":"Piawah","year":"2019","journal-title":"NPJ Breast Cancer"},{"issue":"5","key":"coi200035r21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jamaoncol.2019.6650","article-title":"Effect of pembrolizumab plus neoadjuvant chemotherapy on pathologic complete response in women with early-stage breast cancer: an analysis of the ongoing phase 2 adaptively randomized I-SPY2 Trial.","volume":"6","author":"Nanda","year":"2020","journal-title":"JAMA Oncol"},{"issue":"26","key":"coi200035r23","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1200\/JCO.2011.39.2779","article-title":"Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 trial\u2014CALGB 150007\/150012, ACRIN 6657.","volume":"30","author":"Esserman","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6871","key":"coi200035r24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer.","volume":"415","author":"van \u2019t Veer","year":"2002","journal-title":"Nature"},{"issue":"17","key":"coi200035r25","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/jnci\/djj329","article-title":"Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.","volume":"98","author":"Buyse","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"coi200035r26","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/annonc\/mdx173","article-title":"Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis trial.","volume":"28","author":"Earl","year":"2017","journal-title":"Ann Oncol"},{"key":"coi200035r27","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz394.003","article-title":"KEYNOTE-522: phase 3 study of pembrolizumab + chemotherapy vs placebo + chemotherapy as neoadjuvant treatment, followed by pembrolizumab vs placebo as adjuvant treatment for early-stage high-risk triple-negative breast cancer.","volume":"30","author":"Schmid","year":"2019","journal-title":"Ann Oncol"},{"issue":"4","key":"coi200035r28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1470-2045(18)30111-6","article-title":"Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.","volume":"19","author":"Loibl","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"coi200035r29","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis.","volume":"26","author":"Spring","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"7","key":"coi200035r30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer.","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"issue":"22","key":"coi200035r31","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy.","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"key":"coi200035r4","unstructured":"US Food and Drug Administration. Guidance for industry: pathological complete response in neoadjuvant treatment of high-risk early-stage breast cancer: use as an endpoint to support accelerated approval. Accessed November 26, 2017. https:\/\/www.fda.gov\/media\/83507\/downloadhttps:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm305501.pdf"},{"key":"coi200035r5","unstructured":"European Medicines Agency. The role of pathological complete response as an endpoint in neoadjuvant breast cancer studies (EMA\/CHMP\/151853\/2014). Accessed March 25, 2018. https:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/04\/WC500165781.pdf"},{"key":"coi200035r22","unstructured":"College of American Pathologists. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Accessed March 25, 2018. https:\/\/documents.cap.org\/protocols\/cp-breast-invasive-18protocol-4100.pdf"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2768226\/jamaoncology_yee_2020_oi_200035_1599155066.86542.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T15:33:33Z","timestamp":1599752013000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2768226"}},"subtitle":["Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2020.2535","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}